Chem. J. Chinese Universities ›› 2021, Vol. 42 ›› Issue (8): 2493.doi: 10.7503/cjcu20210212

• Physical Chemistry • Previous Articles     Next Articles

Construction of a Novel S-scheme CdS-BiVO4 Heterojunction Photoelectrodes and Research on Hydrogen Production

XUE Jinbo1(), GAO Guoxiang1,2, SHEN Qianqian1, LIU Tianwu1,2, LIU Xuguang1,2, JIA Husheng1,2   

  1. 1.Key Laboratory of Interface Science and Engineering in Advanced Materials,Ministry of Education
    2.College of Materials Science and Engineering,Taiyuan University of Technology,Taiyuan 030024,China
  • Received:2021-03-29 Online:2021-08-10 Published:2021-08-05
  • Contact: XUE Jinbo E-mail:xuejinbo@tyut.edu.cn

Abstract:

The single component photocatalysts have low photocatalytic hydrogen production efficiency due to the serious recombination of photogenerated electrons and holes and the mismatch of redox capacity and light absorption range. CdS/BiVO4 and BiVO4/CdS S-scheme heterojunction film photoelectrodes were prepared via chemical bath deposition and successive ionic layer adsorption and reaction method, respectively. The morphology, structure, optical and photoelectrochemical properties of the two film electrodes were characte-rized by scanning electron microscopy(SEM), X-ray diffraction(XRD), ultraviolet-visible(UV-Vis) spectro-scopy, and electrochemical impedance spectroscopy(EIS), and the photocatalytic and photoelectrocatalytic hydrogen production properties of the two film electrodes were tested. The results show that S-scheme heterojunction formed between CdS and BiVO4, BiVO4/CdS shows the best photocatalytic hydrogen production performance, while CdS/BiVO4 shows the best photoelectrocatalytic hydrogen production performance. With the help of surface photovoltage technology, the formation process of the built-in electric field and the carrier transport mechanism of S-scheme heterojunction in the two film electrodes are explored.

Key words: S-scheme heterojunction, Photoelectrode, Internal electric field, Hydrogen production

CLC Number: 

TrendMD: